Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary

Kasiske, Bertram L. ; Zeier, Martin G. ; Chapman, Jeremy R. ; Craig, Jonathan C. ; Ekberg, Henrik LU ; Garvey, Catherine A. ; Green, Michael D. ; Jha, Vivekanand ; Josephson, Michelle A. and Kiberd, Bryce A. , et al. (2010) In Kidney International 77(4). p.299-311
Abstract
The 2009 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline on the monitoring, management, and treatment of kidney transplant recipients is intended to assist the practitioner caring for adults and children after kidney transplantation. The guideline development process followed an evidence-based approach, and management recommendations are based on systematic reviews of relevant treatment trials. Critical appraisal of the quality of the evidence and the strength of recommendations followed the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach. The guideline makes recommendations for immunosuppression and graft monitoring, as well as prevention and treatment of infection,... (More)
The 2009 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline on the monitoring, management, and treatment of kidney transplant recipients is intended to assist the practitioner caring for adults and children after kidney transplantation. The guideline development process followed an evidence-based approach, and management recommendations are based on systematic reviews of relevant treatment trials. Critical appraisal of the quality of the evidence and the strength of recommendations followed the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach. The guideline makes recommendations for immunosuppression and graft monitoring, as well as prevention and treatment of infection, cardiovascular disease, malignancy, and other complications that are common in kidney transplant recipients, including hematological and bone disorders. Limitations of the evidence, especially the lack of definitive clinical outcome trials, are discussed and suggestions are provided for future research. This summary includes a brief description of methodology and the complete guideline recommendations but does not include the rationale and references for each recommendation, which are published elsewhere. Kidney International (2010) 77, 299-311; doi: 10.1038/ki.2009.377; published online 21 October 2009 (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
systematic review, practice guideline, kidney transplantation, disease management, KDIGO
in
Kidney International
volume
77
issue
4
pages
299 - 311
publisher
Nature Publishing Group
external identifiers
  • wos:000274051700007
  • scopus:75749145002
  • pmid:19847156
ISSN
1523-1755
DOI
10.1038/ki.2009.377
language
English
LU publication?
yes
id
02a77eb1-1ad1-43b8-8b0e-c30a82980cb4 (old id 1546923)
date added to LUP
2016-04-01 13:20:11
date last changed
2022-04-21 20:46:28
@article{02a77eb1-1ad1-43b8-8b0e-c30a82980cb4,
  abstract     = {{The 2009 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline on the monitoring, management, and treatment of kidney transplant recipients is intended to assist the practitioner caring for adults and children after kidney transplantation. The guideline development process followed an evidence-based approach, and management recommendations are based on systematic reviews of relevant treatment trials. Critical appraisal of the quality of the evidence and the strength of recommendations followed the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach. The guideline makes recommendations for immunosuppression and graft monitoring, as well as prevention and treatment of infection, cardiovascular disease, malignancy, and other complications that are common in kidney transplant recipients, including hematological and bone disorders. Limitations of the evidence, especially the lack of definitive clinical outcome trials, are discussed and suggestions are provided for future research. This summary includes a brief description of methodology and the complete guideline recommendations but does not include the rationale and references for each recommendation, which are published elsewhere. Kidney International (2010) 77, 299-311; doi: 10.1038/ki.2009.377; published online 21 October 2009}},
  author       = {{Kasiske, Bertram L. and Zeier, Martin G. and Chapman, Jeremy R. and Craig, Jonathan C. and Ekberg, Henrik and Garvey, Catherine A. and Green, Michael D. and Jha, Vivekanand and Josephson, Michelle A. and Kiberd, Bryce A. and Kreis, Henri A. and McDonald, Ruth A. and Newmann, John M. and Obrador, Gregorio T. and Vincenti, Flavio G. and Cheung, Michael and Earley, Amy and Raman, Gowri and Abariga, Samuel and Wagner, Martin and Balk, Ethan M.}},
  issn         = {{1523-1755}},
  keywords     = {{systematic review; practice guideline; kidney transplantation; disease management; KDIGO}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{299--311}},
  publisher    = {{Nature Publishing Group}},
  series       = {{Kidney International}},
  title        = {{KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary}},
  url          = {{http://dx.doi.org/10.1038/ki.2009.377}},
  doi          = {{10.1038/ki.2009.377}},
  volume       = {{77}},
  year         = {{2010}},
}